FDA NDC Directory · JSON-LD · Markdown

WYOST

NDC 61314-228 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic namedenosumab
Labeler / ManufacturerSandoz Inc
Marketing categoryBiologic License Application · App BLA761362
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsDENOSUMAB (120 mg/1.7mL)
Marketing started20250602
Package count1

External sources

Source: openFDA. Public-domain (CC0).